GLOBAL IMMUNE CHECKPOINT INHIBITORS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 135

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to suppress the anti-tumor activity of the immune system thereby suppressing the immune response against the cancer cells. The study of these proteins and pathways has led to the development of a number of immune checkpoint inhibitors as therapies against cancer. Initial preclinical studies showed that antibody blockade of the immune checkpoint molecule CTLA-4 resulted in successful anti-tumor immune responses in the murine cancer models. This was then followed by studies targeting the PD-1/PD-L1 pathway. Ipilimumab and Yervoy were the first immune checkpoint inhibitors introduced in the market. With the promising results of Yervoy, several anti-PD-1 and anti-PD-L1 antibodies have been developed. Although there are number of other checkpoints that have been studied, such as LAG-3 and TIM-3, the only approved immune checkpoint inhibitors include CTLA-4, PD-1 and PD-L1.

Scope of the Report:
The worldwide market for Immune Checkpoint Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Immune Checkpoint Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Bristol Myer Squibb
- AstraZeneca
- Merck & Co.
- Roche / Genentech
- Incyte Corporation
- NewLink Genetics
- ArGEN-X
- Seattle Genetics
- Pfizer
- MacroGenics
- Celldex Therapeutics
- CureTech
- Immutep
- Innate Pharma
- Sorrento Therapeutics
- GlaxoSmithKline
- GITR, Inc

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- PD-1/PD-L1
- CTLA-4

Market Segment by Applications, can be divided into
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Melanoma
- Blood Cancer
- Other

There are 15 Chapters to deeply display the global Immune Checkpoint Inhibitors market.
Chapter 1, to describe Immune Checkpoint Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Immune Checkpoint Inhibitors, with sales, revenue, and price of Immune Checkpoint Inhibitors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Immune Checkpoint Inhibitors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Immune Checkpoint Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Immune Checkpoint Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(May 19)

Scope of the Report: The worldwide market for Transilluminators is expected to grow at a CAGR of roughly over the next five years, wi...

(May 19)

Scope of the Report: The worldwide market for Microbial Products is expected to grow at a CAGR of roughly over the next five years, w...

(May 19)

Scope of the Report: The global Protein Labeling market is valued at million USD in 2018 and is expected to reach million USD by the ...

(May 19)

Scope of the Report: The worldwide market for Microbial Growth Media is expected to grow at a CAGR of roughly over the next five year...

(May 19)

Scope of the Report: The worldwide market for Protein Kinase Inhibitor is expected to grow at a CAGR of roughly over the next...

(May 19)

Scope of the Report: The worldwide market for Cancer Biomarkers is expected to grow at a CAGR of roughly over the next five years, wi...

GLOBAL IMMUNE CHECKPOINT INHIBITORS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use MAY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy